Improving diversity in cancer research trials: The story of the cancer disparities research network

Melissa A. Simon, Erika E. De La Riva, Raymond Bergan, Carrie Norbeck, June M. McKoy, Piotr Kulesza, Xin Qi Dong, Julian Schink, Linda Fleisher

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

The participation of racial and ethnicminorities and underserved populations in clinical trials is a critical link between scientific innovation and improvements in health care delivery and health outcomes. However, these population groups continue to be underrepresented in research. We describe the development of the Cancer Disparities Research Network (CDRN) to improve minority and underserved populations' participation in biobanking research. Between February and October 2011, we conducted a regional assessment to identify challenges and opportunities for cancer trials and biobanking research across the CDRN. Representatives from ten CDRN biorepository facilities completed an online survey assessing their facilities' minority biospecimen collection, biobanking practices, and education/outreach initiatives. Representatives of eight facilities also participated in stakeholder interviews. The majority (70 %) of facilities reported that specimens were available for research, although only one tenth of these specimens were from non-White patients. Most facilities collected a patient's age, gender, race, medical history, and ethnicity with samples; however, less than half also collected family health history, education level, household income, or primary language spoken. In addition, few institutions collected Asian orHispanic subgroup information.Only a few reported biospecimen collection outreach programs specifically targeting minority and underserved populations.Biospecimen directors and administrators indicated that funding, biospecimen sharing procedures, and standardization barriers limited their facilities from collaborating in biospecimen collection programs, despite their great interest. These findings suggest that the CDRN can provide opportunities for collaboration, resource sharing, and fostering of research ideas to address cancer disparities in biospecimenresearch.

Original languageEnglish (US)
Pages (from-to)366-374
Number of pages9
JournalJournal of Cancer Education
Volume29
Issue number2
DOIs
StatePublished - Jun 2014

Keywords

  • Biobanking
  • Cancer research
  • Clinical trials
  • Minority and underrepresented populations

ASJC Scopus subject areas

  • Oncology
  • Public Health, Environmental and Occupational Health

Fingerprint Dive into the research topics of 'Improving diversity in cancer research trials: The story of the cancer disparities research network'. Together they form a unique fingerprint.

  • Cite this

    Simon, M. A., De La Riva, E. E., Bergan, R., Norbeck, C., McKoy, J. M., Kulesza, P., Dong, X. Q., Schink, J., & Fleisher, L. (2014). Improving diversity in cancer research trials: The story of the cancer disparities research network. Journal of Cancer Education, 29(2), 366-374. https://doi.org/10.1007/s13187-014-0617-y